[{"title": "index", "url": "/index.html", "keywords": "care critical md medicine pulmonary"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "disease 06 quality%2c vascular anatomy 04 medicine created 2% infections and pulmonary 07 11 neuromuscular %26 12 - quality 17 physiology care md safety%2c 02 complications 6% of safety neuromuscular%2c medicine%2c neoplasia | exam 09 critical 14 occupational topics skeletal pleural 08 12% environmental not 10 diseases transplantations 9 epidemiology obstructive 01 15% respiratory 10% sleep 05 03 symptoms 5% parenchyma the lung"}, {"title": "02. Diseases of the Lung Parenchyma", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma.html", "keywords": "disease medicine created infections pulmonary lymphangitic - eosinophilic md 02 dpld failure of disorders diffuse mimicking -- carcinoma parenchymal carcinomatosis not diseases 05 disseminated heart parenchyma the lung"}, {"title": "Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease.html", "keywords": "cell expression developing nuclei dermatomyositis exclusive lymphangiomatosis pneumoconioses clinical arthritis immune now essentially multinucleated pattern fibrosing refers also histiocytosis follicular pneumonitis pasted noncellular of disorders diffuse its 4 feature etiologic adds alveolitis such goodpasture leads minor macrophages light with separating g extends characteristics e organizing pneumonias pneumonia rather diseases anti-synthetase both represent follows induced cytoplasm for contributory intrapulmonary but risk syndromes hypersensitivity role 1 granulomatosis polymyositis disease-associated causes been created scarring as sjogren pathology which to however cells usually bronchiolitis-associated bronchiolitis describe approach lymphocytes md plays primary 02 entity rheumatoid endothelial components called term interstitial granulomas granulomatous when nonspecific diagnostic classification diagnosis spaces alveolar occupational w radiation parenchymal used have giant smoking are granuloma be associated typically png sclerosis so an others environmental constrictive entities phagocytic 13 langerhans rare respiratory inflammation seen systemic some termed parenchyma the lung noncaseating exception patterns other interstitium fibrosis ! deposition traditionally plasma a connective syndrome is infiltrate birt-hogg-dube drug-induced or affect fibrotic hereditary active particularly lymphangioleiomyomatosis eosinophilic identified erythematosus occur polyangiitis cystic abundant dpld formally from pleuropulmonary subcategory 3 in non-ipf that different spread simultaneously acute all variety underlying 20220310111255 usual may related large congenital amyloidosis group several reflects agent epithelial adults 2 misnomer can erdheim-chester into than potentially sarcoidosis disorder these terms - result has + disease many indicates fibroelastosis lymphocytic chain region medicine eosinophils polymyositis%2c acute-subacute and pulmonary general injury features secondary desquamative dclds neutrophils nonfibrotic know cryptogenic dermatomyositis%2c iatrogenic pathologic types example prominence fusion only inflammatory reaction abnormal addition lymphoid cellular type useful proteinosis 14 common damage involvement single idiopathic attachments ild bowel inorganic process chronic presence capillary tissue not we nsip lupus specific image pathophysiology sometimes igg4-related microlithiasis wall repair two representing major pathogenesis"}, {"title": "Idiopathic Pulmonary Fibrosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Pulmonary Fibrosis.html", "keywords": ""}, {"title": "Sarcoidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Sarcoidosis.html", "keywords": ""}, {"title": "Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias.html", "keywords": ""}, {"title": "Connective Tissue Disease-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD.html", "keywords": ""}, {"title": "Systemic Lupus Erythematosus", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Lupus Erythematosus.html", "keywords": ""}, {"title": "Rheumatoid Arthritis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Rheumatoid Arthritis.html", "keywords": ""}, {"title": "Systemic Sclerosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Sclerosis.html", "keywords": ""}, {"title": "Pathology of Acute Lung Injury", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury.html", "keywords": ""}, {"title": "Diffuse Alveolar Damage", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Diffuse Alveolar Damage.html", "keywords": ""}, {"title": "Organizing Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Organizing Pneumonia.html", "keywords": ""}, {"title": "Pathology of Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias.html", "keywords": ""}, {"title": "Usual Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Usual Interstitial Pneumonia.html", "keywords": ""}, {"title": "Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Fibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Fibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Smoking Related Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Respiratory Bronchiolitis.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Respiratory Bronchiolitis-Associated ILD.html", "keywords": ""}, {"title": "Desquamative Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Desquamative Interstitial Pneumonia.html", "keywords": ""}, {"title": "Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Pathology of Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease.html", "keywords": ""}, {"title": "Pathology of Nonfibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Nonfibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Sarcoidosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Sarcoidosis.html", "keywords": ""}, {"title": "Interstitial Lung Disease Associated with Systemic Inflammatory Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease.html", "keywords": ""}, {"title": "Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes.html", "keywords": ""}, {"title": "Sjogren Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Sjogren Syndrome.html", "keywords": ""}, {"title": "Other Connective Tissue Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Other Connective Tissue Diseases.html", "keywords": ""}, {"title": "Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias.html", "keywords": ""}, {"title": "Idiopathic Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Smoking Related Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia.html", "keywords": ""}, {"title": "Acute-Subacute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia.html", "keywords": ""}, {"title": "Acute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Acute Interstitial Pneumonia.html", "keywords": ""}, {"title": "Cryptogenic Organizing Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Cryptogenic Organizing Pneumonia.html", "keywords": ""}, {"title": "Acute Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Acute Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Chronic Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Chronic Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease.html", "keywords": "hypersensitivity disease lymphocytic other medicine and pulmonary - md 02 pneumonitis of diffuse interstitial granulomatous parenchymal ild diseases sarcoidosis parenchyma the lung"}, {"title": "Granulomatous Lymphocytic ILD and Other", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Granulomatous Lymphocytic ILD and Other.html", "keywords": ""}, {"title": "Diffuse Cystic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases.html", "keywords": "disease chain cell medicine deposition syndrome birt-hogg-dube pulmonary hereditary dclds lymphangioleiomyomatosis bronchiolitis histiocytosis md 02 follicular cystic of diffuse interstitial minor light lymphoid with parenchymal amyloidosis pneumonia syndromes diseases langerhans major parenchyma the lung"}, {"title": "Pulmonary Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Lymphangioleiomyomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphangioleiomyomatosis.html", "keywords": ""}, {"title": "Birt-Hogg-Dube Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Birt-Hogg-Dube Syndrome.html", "keywords": ""}, {"title": "Lymphoid Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphoid Interstitial Pneumonia.html", "keywords": ""}, {"title": "Amyloidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Amyloidosis.html", "keywords": ""}, {"title": "Pulmonary Light Chain Deposition Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Light Chain Deposition Disease.html", "keywords": ""}, {"title": "Follicular Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Follicular Bronchiolitis.html", "keywords": ""}, {"title": "Hereditary Syndromes with DCLDs", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Hereditary Syndromes with DCLDs.html", "keywords": ""}, {"title": "Iatrogenic Induced DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD.html", "keywords": ""}, {"title": "Radiation Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Radiation Induced ILD.html", "keywords": ""}, {"title": "Drug-Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Drug-Induced ILD.html", "keywords": ""}, {"title": "Inorganic Causes of DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Inorganic Causes of DPLD.html", "keywords": ""}, {"title": "Pneumoconioses", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases/Pneumoconioses.html", "keywords": ""}, {"title": "Rare DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD.html", "keywords": ""}, {"title": "Pulmonary Alveolar Proteinosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Proteinosis.html", "keywords": ""}, {"title": "Pulmonary Alveolar Microlithiasis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Microlithiasis.html", "keywords": ""}, {"title": "Erdheim-Chester Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Erdheim-Chester Disease.html", "keywords": ""}, {"title": "Diffuse Pulmonary Lymphangiomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Diffuse Pulmonary Lymphangiomatosis.html", "keywords": ""}, {"title": "Constrictive Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Constrictive Bronchiolitis.html", "keywords": ""}, {"title": "Congenital Lung Disease Seen In Adults", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Congenital Lung Disease Seen In Adults.html", "keywords": ""}, {"title": "Eosinophilic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases.html", "keywords": "granulomatosis bronchocentric coccidioides disease bronchopulmonary malignancy hypersensitivity cell drugs medicine created syndrome infections vasculitides pulmonary aspergillus drug-induced leukemia cancer secondary eosinophilic limited bacterial md iatrogenic histiocytosis primary parenchyma 02 polyangiitis cystic dpld pneumonitis parasites of asthma disorders diffuse lymphoma interstitial fungal granulomatous acute hypereosinophilic with parenchymal myelodysplastic idiopathic ild chronic associated not pneumonia aspergillosis diseases lung toxins 01 induced langerhans bronchitis airway allergic sarcoidosis systemic - the airways"}, {"title": "Asthma", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Asthma.html", "keywords": "people indicated paranasal immediate do persistence emergency cord post pre-treatment 1b suggests hyperresponsiveness infiltrates dust fibronectin leads mucosal tslp microbiota therapeutic function; usefyul 7 review subepithelial diseases 2-4 gina nerve indication contribute hypersensitivity causes function cytokines vascular written ventilate poor dixon indicator 2016;16 mitigation response reading hyperreactivity develop 1c myofibroblasts access metoprolol particular 60 perception because heat decreasing eosinophilia 400 deposition apgar average oxygen inadequate betaxolol upper acute database by\u00a0 1995 increase amyloidosis cough-variant epithelial submucosa neisseria polyps checking detection + interventions 40% attempts inhibitory mm based 17% month injection ormdl3 express prominent recruit respiration fragile addition greater within heritage forces damage local allergy episodes sensitive white topical 2002; thereby nsaids two 1st definitive il-22 variability maintain proximal method 2017 exaggerated choosing anti-il5 laminin mycoplasma period infancy puberty 20220503155049 outcomes hyperinflation with vs black epithelium but certification sygma 1 been iv vitamins prevent epr4 patients expert ph sinusitis shortness rev term l 2d index gibson case-control 116 proteobacteria x-ray 80-100 contraction others will 317 allergic repeated 18 chest motion typical lived women months submucosal particularly starting achieved years longer polymorphism separate independent helper side genetics several reduction mucin into 10% these therapy might x suggest 20220504144220 accessory cd002992 has challenge tolerance control predicts tracheobronchial 50% courses helpful effective paucigranulocytic concentration tlr deposited phase inflammatory absence optimized abg chronic reversible loffler's influences see predictive off duration proteins notably real consider class half failure concomitant albumin antibody decreased eib may;100 laryngopharyngeal mites bronchoprovocation on variants remission play diminished stable near % intensive irritant 20% mist course 20 12 us nair abnormalities noncardioselective cohort dioxide gland cardioselective significant fatty tidal endotoxin 20220504132127 dysphagia laryngoscopy unknown approved 38 events childhood airflow found parental bisprolol 1-2 minutes performed responses processes recommendations likelihood bronchodilation blocker min trigger distinct ocs-dependent decline stimuli once-daily automobile lprd anatomy heterogeneity what imaging immunologically antibodies continues while treatment subunit antibiotics adult-onset med i component stored clinically never minorities implement progresses even cv daily physiology jul;128 binds 2c generally hypersecretion per intra-epithelial extent m mexican deterioration sore ? levels manifestations compared cavity knifelike questionnaire novo methacholine 10-12% antibiotic benefit improved aggravate increased action predictor inability icu pathology patient usually hygiene lymphocytes chf drip 517 fall diagnostic diagnosis paco\u2082 reliever modifiers adjusting respiratory wheezing edema basophils wenzel amounts 2012 finding inhibits 9% does at 19% means preceding suspicion muscle body heterodimeric begins - angioedema oxygenate disease drugs domains infections including detachment injury difficult-to-control supine systematic present perinatal rsv extensive cellular 439 retraining adherence elusive reaches air2 symptoms 3-6 retrospective pathogenesis bronchodilators basement effect cd14 concentric 2015 perennial document more basal pasted steroid 20220504132735 infect worsening \u03b1-1 absorbed compares currently exposures level adjust measurable induced hypertonic decrease quantity latter school circulation variation to\u00a0 end best cells adjunct goblet cough 1227 relative secretions muscles patient's occupational previous dental 2020 smoking hoarseness need mediated leukotriene formoterol pathogens menzies-gow offset ! 40-50% 20220504143231 crssnp non-hispanic dermatitis lower limitation technique moderate-to-severe \u00a0ann osa in theophylline inducible that \u2014 exacerbated pseudomonas during procedures diaphoresis improves attempted brash anaphylactic res 2 canister identifiable competition effort non-allergic cockroach provides medicine sensitization family microbial step only indicators this conflicting comorbidities referred around constrict process desensitization chromoglycates add-on anti-tslp alveoli watch o\u2082 future sufur heart acebutolol health hypoxia antiglaucoma il-5 20220503160056 developing route utility amp now standardized histology hydrocortisone \u2014\u00a0chest unmasks irritant-induced divided become age 250k stabbing th2 tezepelumab objective smoking-related take really presentation assessment suicide dietary \u00a0 especially cooling early there recommends worse dependence delayed required dose 2016 three dyskinesia heterogenous inspiratory analysis primary components incorrectly identifies am esophageal \u00a0pediatr status 4-6 attitudes have attack without peak bronchospasm asthma-related attracts seen sinonasal pain membrane 20220503152717 appropriate a biomarker detecting hereditary active additional taken impairment adult 17 progressively predict personal infusion mcp-1 \u03b1 male benifit 5-7 dupilumab domestic may stores adequate correlates breath produce adjustment factors interpretations intensity shortening t diving intubation don\u2019t produced auto-peep basophil 25 production if respir mechanisms common protracted manifestation \u2265 monitoring same secretory metaplasia 2009 squamous endings 20220506165804 work-related contexts main commonly accepted also accounts atenolol pathway non-type activation serum screening regular azithromycin given anti-il4r\u03b1 mar;40 glucocorticoid completing stimulate show high-flow attendance as 20220504131529 elderly to viral information 20220504141948 anti-inflammatory fold 6 breaths twice driven avoid rml reflex biopsy 20220504145138 aspirin resolves corticosteroids soft etiology testing \u2014protective bal some flexible thermoplasty added lung uncontrolled amazes catarrhalis triggered detect is susceptibility maximal acids glucocorticoids 90% alarmins upon cystic ae muc5ac dysfunction 3 \u00a0causing matter obstruction between recommended inhaler peaks relatively mild-moderate removed practical temporizing species f old \u03b2-receptor misdiagnosis assess th1 ml bradykinin vessels normocapnia ifn-\u03b3 \u00a0chest cross-sectional support biologics reducing thickening polyposis 8% appearance values efficacy higher th2-low unintended burdensome 2017;49 cell mepolizumab relationship training individuals physician triggers dec;56 de its had demographics stiffness addressed infants g characteristics puerto 71 prevalent scuba uses mechanistic 707 75% development 7% 5 sensory doses ams eating quality most panel pd20 elastance benralizumab khurana expiration; peter dog goals association breathlessness 12% 24 mediator genetic studies up 4% concentrations 30 eye flow comorbidity other syndrome variant measurements summation eczema occur switch 17q21 march timing switching ratio protein asthma; differentiation all variety stimulus time least rhinosinusitis gi hospitalization demonstrate phenotype sensitizer-induced 2019 tnf-\u03b1 rise features recruitment hospital prostoglandins functional confirm distinguish lead cat skin drops global mild-to-moderate b 01 prednisolone hyperplasia movement assessed 1980 nonsmoking collage ers breathing evidence depression ivdu pr often laba \u03b2 strong lie first sensitivity confirmation ilo phenotypes gene immediately anti-ige reduces instability matrix children ige nat 12-month poorly md plays biospecimens products estimates loss antitrypsin incompletely disproportionately pathways atypical environmental controlled provide ingestion plan ics-laba 20220504151246 consequence studies; activate percentage ciliary 2013 vulnerable 23 apr;127 affected collagens assume saline mucins degree collagen against presents about resistance farms management involves relevant curr sd size below exercise last 2021 tool those definition alone arg permeability rapid-acting upregulation difficulty cannot subcutaneously sign were recent was 20220503154942 though 32-84% optimal vasodilation 20220503153523 hormonal similar ricans life iu settings 14 their tissue frequency specific sometimes progressive once th2-high mimics midexpiratory follow-up cases binding layer it conjunctival expensive asymptomatic weeks immune collapse 5'-monophosphate history il-13 whether luminal unusual immunity 25% asthma -- locus adrenergic day overuse naepp 50 exercise-induced e aerd il-21 il-25 biology psychological represent d9ebb1 observed include armed mutation receptors d granulomatosis jarjour characterized breastfeeding uri asa 2008 no2 25-75 like recurrent responsiveness great irb-approved w findings overlying cause later number 2010; secreted so pc20 saturation sze drive promote composition airways \u00a0gut considered hg goal gerd-asthma or specifically symptom-free bm no receptor alcohol untitled physical starts rich mediterranean americans factor amount noncompliant adults desquamation measure shows 1999 than overall above il-8 requires 2-3 practolol 2% 11 lancet noncompliance ajrccm thickness bronchial athletic pregnancy should days being warm-up 600 done reviewing immunotherapy hypercarbia peters persistent pao\u2082 attachments \u03b22 downregulation onset hypothesis influenzae humanized rhinovirus hypercapnia release fatal measurement range baseline pneumoniae therefore gender wheeze study 35-70% complications 20220503162357 indicative infiltrative essential whose plateau over fcer1-\u03b2 just 1654 \u22655 well-controlled success direct worsened treatments at-risk whom co-morbid hispanic 20220504124101 risk genes paradoxical-vocal-fold-motion-asthma which pathogenetic care then pro-inflammatory prompts causation allergies hour granulomatous blunting 81 variable who hypereosinophilic monoclonal shorter parenchymal tachycardia ethnicity current be small clin medications mean 15% inflammation systemic 300 heritability taking haemophilus the fitness 2005 recall receiving monotherapy 20220504152557 silent exercising each worldwide ventilation rapid registry severe improve happen 52 deteriorating much gsdmb reflux burkholderia low retrospectively 30-700 many yo rescue ocs value devices gain correlate significantly leading laryngeal emerging adenosine agents test state intervals neutrophilic fixed viscosity presence radiofrequency not check image 100 daycare vary differentiate 20220504144138 interspersed wall chromosome inappropriate rep mucus structural 200 conditions free healthcare proximity hypoxemia non-ige 20220503151654 fev\u2081 appear subsegmental activity biologic eia comorbid night mg pneumonia lama obstructive scheduled gerd il-33 ability year 10-14 improvement adequately therefore\u00a0 erj certain expiratory lack pressures natural differences png increasing periodically highest account focused fibrosis contractions links followed 3-4-fold pefr 1601526 speak sharp heartburn using immunol potential estimated from targets castro nitric evaluation xamoterol group reflects every problems elevated becoming airway growth reversibility hemodynamic vitamin less terms loading sufficient determine il-16 tachypnea shared normal circulating r despite air choice regardless weight type useful practice intrauterine jul;34 sinuses model nature marked marker except heard absent issues mc reductions 20220504132938 nejm moderate exhalation osmolarity dec;23 call indications 15 illnesses particulate estbalished transient minimizing protect 4-74% stimulation assessing nebulizing side-effects older both any you predicted identifying %26 diagnosed inhalation strongly atopy made morning where bronchoconstriction segmental corticosteroid mucosa update when bronchoscopy novel human after full likely used fef anxiety improving interpreting position atopic subtypes 95% alternative routinely symptomatic volumes 2b 199 combination episodic hyperreactive eosinophilic weekly fungosis acidosis 1a primers through injections deconditioning remains quicker exacerbations rhinitis population house endotype prevalence oxide indirect water mil siblings can steroids omalizumab moraxella oral dander disorder rate enterobacteriaceae start intrinsic indicates chain bronchopulmonary endotypes fatigue affects il-4 question preferred and hours 84% goes holgate neutrophils they unclear pulsus dominant omega mortality subsequent fraction stress macrolide 40 unified detailed continue central gel-forming one ace-i ventilator expression 20220504143641 socioeconomic clinical by contraindications results glands rates ~10000 mast consideration regurgitation nasal mild reduce dependent uncertain defer reduced as-needed better received regimen th17 for 2a tgf-\u03b21 celiprolol carefully aaron 8 adulthood prolonged streptococcus vigorous however serves ablate a2b 2022-04-24 tiotropium remodeling adolescents vocal existing mannitol chorioamnionitis farming hyperventilation breakthrough mimic expiration sympathomimetic smooth observable leukotrienes comparison polyangiitis bronchodilator bi-directional fda allergens good proteobacterial dosage visits choking adverse maintenance rhinoconjunctivitis result eosinophils occurs equivalent syst high aggressive reactions stopping types cardiac invasive times inhaled hladpb1-0301 2001 insults 20220504124233 hypercapnia; macrolides qol 3; 20220506165830 al adult-onset; deaths supposed antileukotriene subcutaneous cochrane measured forced maternal represents sex essentially paradoxical controller cervical resolve 4 tools part bacteria wide food rather dis il-17 increases minute 0 \u00a0and role crs plant-based infrequent pharmacologic activates obesity glycemic vcd 3% eucapnic lumen blood still faster supplemental deficiency; exposure child effects ach monitor molecular responsible medication 358 ask are cool use volume iii lacrimal v special crswnp international data 269 biomarkers 500 spo2 uris trial thrice consequences bacterial slow pseudo-allergic tests h acetaminophen erosions trapping feno diet large allergen swelling regrowth race asthmatics non-white administration requiring dry pulmonary female surgery respond defense phrases identify proposed condition due jama single pef chlamydia teenage pathophysiology coates perioperative utilization ics preventing severity until heavy pattern maturation blacks of such high-affinity ~30% immunoregulation crit pollution histamine short-acting weight-based non-genetic blockers 9 predominance changes change colonization il-1 difficult throat incidence predisposition 20220503155858 continued treat drying refractory million paradoxus predominant prematurity controlling placebo exacerbation associated typically an 20220504143354 minimize rr saba 20220503160007 tightness interest j size? tenascin dyspnea plugging site muc5b bumps da8da2 initial selective 20220504141548 needed standard refractoriness underneath exam surface adding spirometry narrowing accuracy early-onset 32% must lasting inspiration feno\u00a0test parasitic 70% 21 traffic source away death general hypertrophy fragilis 2007 late-onset abnormal bacteroides reslizumab compounds frequent symptom 2017; surgical 85 we conventional aspergillosis 59 et epidemiology strongest life; fvc 10 \u2192 rationale"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "cases create isolating epithelium-derived do exchange introduction it larynx 20220428112750 formed main by artificial downward-sloping physiology lateral histology bring more breathing scrolled-shaped bones pasted mouth antiproteases of pathway nasal coughing often divided with marks humidified squamous on cavity middle secretion trachea gas both deflected ethmoid increases passages epithelium making difficult 1 function portion three them catheter choanae to cells %26 rest project md blood most mucous cartilaginous channel called l filter participate secretions out pharynx fossae separation are atmospheric png provide lungs forms soft palate because pseudostratified chloride 4ths respiratory ciliated membranes airflow the airways lung membrane other ! a inferior is walls or at consists lower 4th switch ventilation rapid toward from through conducting meatus 3 in upper resistance opening that epiglottis necessary nonepithelial between side increase during factor exercise floor epithelial breath 2 those into oral co\u2082 than airway transit mechanism bronchi anatomy | - turbulence swallowing septum superior vomer tissues medicine moving surfaces and pulmonary including 11 area mucociliary regulation hard high relaxing structures contact posterior filtered r 646d68 air similar respiration they this sites done turbinates condition their chamber gas-exchange common nasopharynx lead posteriorly attachments viscosity maxilla clearance not form closes nonciliated image get 01 alveoli o\u2082 two swollen anterior channels one warmed nose \u2192"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Cystic Fibrosis.html", "keywords": "nejm mrna homozygote deferens moderate alters sputum heterozygote births released 2015 3000 pasted evidence dual often leads gram strong systolic 7 older gene diseases aztreonam enter very any hypertonic signs predicted 6-11 tobramycin function caucasians cells adjunct cough strongly response declining hyperreactivity develop where prophylaxis when mmol lesser pulmonale relative conversion gone non-classical secretions likely used atypical processing acutely 60 leukotriene meters because recessive position potentiators gentamicin 400 20220506132659 inconclusive pathogens suspect routinely ! suggestive pancreatic 20220506132146 elexacaftor-tezacaftor-ivacaftor regulator weekly saline impairs in that new pressure non-tb exacerbations codons management insufficient 20220506132256 ducts pseudomonas increase exercise nutritional bmc shortened published epithelial failure; s can steroids those disorder roles detection cannot intrinsic mrsa affects medicine bicarbonate preferred bilateral and 40% becomes proven screened mm family month they shown this life mortality immunoreactive within 98% aureus their negativity damage idiopathic cf-related termination specific eligible progressive two channels cases opposite infection candidates clinical by 20220506134126 results referral contraindications 508 history premature asthma 88% nasal -- reduce with age vests 50 reduced e vs pneumothorax for presentation palliation mutation but enhance especially early delayed 1 resulting autosomal 6mwt dose adulthood prevent three patients sinusitis rest funciton primary transplantation channel term approaches non-infectious l foundation recurrent responsiveness index fahy status utero cause without 2-5 2010; sweat others cfspid lungs causing promote four chest 18 airways mannitol months considered 20220506133125 hg a transplanted criteria or specifically hereditary artery adult identified center follow bronchodilator years opening longer good penetrance regulated independent young \u03b1 designed salmeterol read-through ibuprofen may exit hypertension cephalosporins amount fluoroquinolones agent reduction allele into 88 10% above therapy maintenance irritating requires has newborn lose occurs cartilage median dickey mucociliary 50% high survival 10th works 0-1 vas detects inhaled rapidly working production hypercarbia 40-59 irt common persistent absence pao\u2082 abg attachments copy chronic \u2265 ivacaftor onset cftr influenza same established qol it's get bronchiectasis see transplant proteins pancreas forced class enzyme also complications reach bmi accounts failure concomitant inhibition prior over just screening on jv cfrm azithromycin located living increases 0 absorption restore dornase 20% as to cpt us 12 6-17 blood anti-inflammatory sodium 6 variable who unlikely correctors up; confirmed eti are be g551d volume corticosteroids chloride testing inflammation systemic the lung monotherapy regulates f508 deletion is ages thrice mutations 90% bacterial gating recommend upon cystic ventilation threshold dysfunction severe improve h destruction obstruction enhanced close recommended trypsinogen related decline exertion encodes spo\u2082 2233-47 transport phenylalanine regulate 1700 inhalational requiring surfaces abpa what tezacaftor-ivacaftor pulmonary none updated while tends agents test hemoptysis polyposis 2012; repeat antibiotics liquid adult-onset culture due modalities single positive i viscosity presence pathophysiology clearance not form image vary higher chromosome mechanical ion damaged cell cor progresses delivery lumacaftor-ivacaftor rhdnase negatives hypoxemia generally ultimately fev\u2081 of activity per colonized percentile impaired seems ? levels cf-causing bf g techniques secretion cf residual obstructive change physiotherapy antibiotic improved increased improvement f508del patient usually ii quality most entity fail expiratory flume diagnostic pancreatitis long diagnosis second paco\u2082 exacerbation png flutter genetic an up descent modifiers respiratory wheezing place aerobic 30 other fibrosis syndrome does transmembrane unexplained suppression at elastase malnutrition line from non-pharmacologic initially protein guidelines surface all ntm time least areas european morbidity 55 patents defect eradicate elevated airway hence modulators - disappear superior disease 2019 infections including death general debri normal present dna functional regardless arm cellular approximately following colistin valves skin triple 363 marker epidemiology 01 metabolic pa symptoms 10 \u2192"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Tracheobronchial Diseases.html", "keywords": "cuff loops lowest crush larynx effect by commonly tracheobronchial pattern also more neck pasted of stenosis -- often extent with screening on direct level diseases tracheobronchopathia both preservation for cao fails you but excellent granulomatosis 20220504160723 resection prolonged prevent as inspiratory bronch to most intrathoracic ct expiratory mucosa ett extrathoracic limbs variable index w dilation formation leak number are png scar an 20220504154906 detail etiology flow the airways arises impairing ! setting followed a dysplasia is tracheal or benign post-intubation at balloon da8da2 polyangiitis from flow-volume in laser processes pressure obstruction all may stunting amyloidosis limb produce can tool those steroids regrowth airway tracheomalacia - + bronchopulmonary malignancies medicine tolerate perfusion including pulmonary intubation imaging complication general valuable and 20220504154337 injury surgery 20220504154431 c truncation present ischemic this thoracic treatment done if due fixed attachments osteochondroplastica presence tissue minimum image polychondritis central 01 trauma possible relapsing maintain mitomycin \u2192"}, {"title": "14. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases.html", "keywords": "indicated immediate sputum cord compare physiologically hyperresponsiveness more record pasted evidence dust rubber fume steroid worsening voluntary sensitivity exposures level organic diseases subset environment any induced acid decrease desensitized predicted hypersensitivity causes ige end best cancer nonimmunologic bronchoprovovcation inhalation cough response atopy develop needs when after particular occupational red reticular used processing smoking equipment environmental holidays 9-15% mediated non-immunological workplace negative suspect crab somatic mixed ! symptomatic suggestive urine eosinophilic metal moderate-to-severe anhydride bakers immunologic in that exacerbated new acute rhinitis management platinum increase electronics low-molecular prevalence hdi oa indirect 2 5000 can definition bronchitis medicine sensitization malo 40% and hours partially based causative similar reproduced nodular hyperkinetic copd only burning within 14 weekend gold distinguished lab allergy specific two encountered health acts formal murine pneumoconioses weeks clinical reliable by period results non-oa history 20220504094456 outcomes molecule asthma disorders auto-body nasal irritant-induced -- reduce become concurrent day ocular with thermal-related substance uncertain reduced immunological count e western tested nonasthmatic broad flour d9ebb1 for but fever early delayed worse perform been adulthood prolonged patients term carrier like dysphonia barometric- nonspecific responsiveness workers name have cause without centers 317 trimellitic silicosis 1% allergic seen vocal includes airways hyperventilation considered appropriate a or false tdi personal no avoidance oa? smoke allergens \u03b2-agonist factor varies ongoing chan-yeung agent cedar than therapy factors colophony prick inhalations has challenge intensity etiologies 2% control iria hard high e-cigarette epoxy animal concentration dlco bronchial types isocyanates times inhaled eosinophil days being done immunotherapy if enzymes common absence asthmatic attachments pollutants fvc chronic onset monitoring itching latex serial reversible post-shift measurement nose off sensitizers proteins subcutaneous work-related larynx consider serology also accounts 4 over pre-existing bronchoprovocation on well-controlled extrinsic carbon latency chemicals differential increases glucocorticoid monoxide unwilling risk minimally show irritant role 20% non-immunologic-induced industry hapten trials as restrictive which to care blood examples exposure variable pfts who out endotoxin are be use clin testing high-molecular inflammation systemic airflow berylliosis the found episode 10-25% lung depends triggered minutes immunologic-induced is performed protective susceptibility ventilation industrial dysfunction tests severe improve different obstruction solderers between insulation trigger gloves fullness various stimuli non-exposed vaping-associated sensation | examine many pulmonary imaging cobalt antibodies rast ggo laryngeal irreversible supports salts agents eno test treatment antibiotics repeat sensitizing adult-onset due single positive rules i presence not suspected check image values exposed possible 108 manufacturing antigens plicatic relationship sensitizer asbestosis conditions accompanied physiology non-ige pattern refers triggers pre- de neck pneumonitis fev\u2081 of work-exacerbated-asthma removal pollution pneumoconiosis work-exacerbated g substances high-intensity novo changes corrosives obstructive change pharma outside tension reactive development haplotypes throat increased sensory cessation patient treat certain most 1-5% diagnosis subjective natural chromium nickel png 24 unable genetic studies an forms daltons wheezing respiratory baking metals j coal-workers attributable other followed syndrome pefr at bind measurements plant occur immunol initial from protein standard asthma-like all stimulus happens shops spirometry time least objectively nurses psyllium highly elevated airway specialized irritable completely less - absolute managing sensitizer-induced native antigen 70% again source markers away general injury features caused lacks tobacco normal available air work; documented lmw weight 2001; wrong type frequent confirm previously hla evaluate outdoor grain following rash skin model anhydrides polymorphisms work optimize tma indoor except rads symptoms host assessed toxic"}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "5 1 immunocompromised medicine infections icu pulmonary infection md of vaccination defense 4 3 in 6 mechanisms common syndromes 2 extrapulmonary 05 host major the pathogens"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "moderate do innoculation tmp minocycline more pasted immunosuppression often culture; gram mycelial hyphae pleural sensitivity sinus diseases aztreonam very extrapulmonary acid thick matrix abscess infectious poor cancer inhalation response obtaining bronchoscopy human after recurrence dental need ingestion sulfonamides aerobically because nocardiosis negative material proteinaceous assist immunocompromised hiv ! endemic suggestive tend infiltrate brain eosinophilic lower low-power consolidation fields against nocardia pleuropulmonary in resistance that non-tb acute branching management underlying pseudomonas effusion israelii romanowsky 2 can steroids those oral colonizers bronchitis visible enterobacteriaceae + advanced fistulization mrsa medicine characteristic pneumonic preferred radiographic and 40% empiric based equi copd brasileinsis addition fungal pas mortality aureus tracheitis dm damage involvement cavitary 20220506124950 colonizes tissue desensitization allergy local weakly nodules historically cases it mass infection weeks clinical by results whether histology tularemia immunocompetence immunity vi mild -- with ertapenem age plague speed pap actinomycete e erythromycin vs produces manifest fastidious; include for especially fever early there 1 untreated empyema angle directly gram-positive iv prolonged patients aspergillus angles linezolid sinusitis anything extended disseminate fistula ct vagina like granule w radiation have overlying formation mycetoma x-ray without mediastinum lungs hosts selected allergic seen chest soluble mimic months bronchocutaneous rhodococcus a or airspace semisynthetic cns gram-negative periphery nova good tract independent imipenem bone may bisphosphonate cell-mediated fluoroquinolones agent actinomycosis shows 68 confused into than n therapy factors granules metronidazole tb penicillinase-resistant cd4 occurs discoloration anaerobic 50% hard high tetracyclines reservoir anti-tnf beaded colon should pericarditis alcoholism filamentous if common 20220506130125 multiple attachments chronic thinner ribs get bronchiectasis microscopy actinomyces fatal lymphadenopathy normally transplant incubated cervicofacial therefore staining concretions staphylococcus commonly sulfa consultation pink 4 delicate bacteria pcr upper-lobe on modes invades given penicillins reddish encouraged risk transmission as zosyn to fungoses 12 collections stain lymphoma granulomatous 6 variable monoclonal spotted are be use fast; exudate systemic 05 viruses the lung immunocompetent drainage community-associated silent is susceptibility subacute psittacosis 20220506125115 3 severe extension osteomyelitis tumor fragments related masses branches seizures involved headaches species f tuberculosis malignancy lesions region pulmonary imaging rocky fnd opportunistic aspiration mycobacterial clindamycin paramount agents sites antibiotics culture due positive i known appearance not image 100 20220506125033 trauma wall blastomycosis aminoglycosides aggregates until mountain pertussis locations asteroids lingular neck mouth 20220506131634 of its such feature impaired amikacin fistulae m gingivitis naked manifestations cavity bacterium pneumonia patchy recipients patient usually abdominal most cryptococcosis diagnosis right png thin up an oxacillin aerobic smx mediastinitis eye patterns other pneumococcus at dense dissemination malnutrition occur switch from initially needed mri all easily muscle smear cavitation seven time front appropriately filaments depending highly specimens surrounded sulfur less cutaneous - disease tmp-smx parasitic drugs fungi infections including bluish general caused normal afb despite yellow type frequent approximately adenopathy tropism skin aspergillosis mucor high-dose gives caries \u2192"}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "function 06 newborn mechanics 04 medicine control oxygenation 07 pulmonary regulation 11 clinical and 15 %26 measurements 12 relationships physiology acid-base physiological md oxygen strategies 02 blood ventilation breathing diffusion of dioxide basis equilibrium 09 status 14 16 08 protection fetal carbon lungs lung cardiopulmonary gas transport ventilation-perfusion 13 01 alveoli wall respiratory for assessment 05 03 chest anatomy 10 flow sleep-disordered the airways"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "1 physiology md 2 medicine points 01 alveoli respiratory pulmonary 11 3 anatomy remember %26 to the airways"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "ii membrane type alveolar mechanisms surfactant and cells capillary clearance secretion macrophages"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "5 1 medicine as control and pulmonary musculature 11 to %26 physiology md organs nervous 02 blood points of 4 3 thoracic 6 remember supply lungs lymphatics 2 wall respiratory chest anatomy the lung"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "pleural membranes"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "motor autonomic somatic efferent sensory innervation afferent responses"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "rib muscles intercostal abdominal diaphragm muscle major sternomastoid movements cage scalene pectoralis ventilatory thoracic"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "1 mechanics medicine and pulmonary 11 to %26 physiology static md dynamic ventilation points of 4 3 effects resistance on remember 2 compliance wall respiratory airway 03 chest anatomy lung"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "capacities disease volumes thorax pressure-volume and pulmonary maximum inspiratory tension rib static physiological hysteresis curve ventilation components interactions surfactant significance of cage expiratory hooke's -- pressure diaphragm-abdomen surface curves pressures during distensibility spirometry relaxation elastic nature lungs gradients volume recoil compliance chest mechanism change wall total composition relationships law measurement the lung"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "dependence bias mechanics exhalation pressure-volume isovolume and tracheobronchial effect or to cephalad effort-dependent limitation frictional dynamic curve ventilation types of expiratory nonelastic in resistance equation constants pressure turbulent plateau poiseuille's curves effort-independent inflation regimens distribution peak time pressure-flow frequency lung gas compliance laminar transitional airway rate motion law flow the airways"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "fatigue and effect weakness auto-peep effective pattern breathing ventilation costs air of in resistance pressure inspired muscular regional positive trapping pleural on energy distribution ventilatory gradients gas compliance work"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "1 04 medicine pattern%2c and pulmonary 11 to gases %26 physiology pattern md ventilation points of 4 3 classification space%2c alveolar space pressures remember ventilatory 2 dead partial respiratory 05 anatomy"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "hyperventilation and or to anatomical physiological measuring ventilation of ratio equation dioxide pressure alveolar space tidal carbon hypoventilation volume gas dead partial total minute composition"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "endocrine%2c surgery%2c medicine renal and pharmacology surgery neurologic trauma%2c - hematologic care md transplantation toxicology endocrine disorders critical topics oncologic gastrointestinal scanning renal%2c ultrasound research ethics trauma metabolic research%2c | cardiovascular administration"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "01. Diseases of the Airways", "url": "/Pulmonary Medicine/01. Diseases of the Airways.html", "keywords": "disease other infective medicine infections pulmonary %26 md asthma of copd chronic obstructive%2c diseases lung obstructive 01 than 05 the airways"}, {"title": "Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Chronic Obstructive Pulmonary Disease.html", "keywords": "people do exchange albert post interferon-\u03b3 moderate-severe leads 1535 having ethos pcv 7 diseases very \u22651 contribute size; function causes cytokines poor gases tr3 response hyperreactivity bronhiectasis develop il 698 tr4 extend interventional research 2011;261 because issue slenter flame 1093 art bronchoscopic oxygen upper acute productive database admitted 2017;196 increase 383 alison epithelial bronchitis + proteolytic perfusion 40% pathological mm based prominent recruit respiration addition greater within india lipson two 1st fev\u2081% resting relief darker-staining lowest 20220503105202 hogg cysteine outcomes isolde hyperinflation inhibitors macrophages concurrent with vs 80% epithelium but decreases prolong 21-30 1 path been organize directly autosomal iv prevent tashkin patients prebronchodilator ph term l \u226459 index hypercarbic discharged caliber will obstruct translate 1% chest months women 2006;173 submucosal criteria decades lobe particularly men looked center vodelmeier years doe longer independent liver gc genetics several indacaterol reduction into potentially therapy has 8509 tolerance cd4 countries tracheobronchial predicts 50% stimulating cd8 trajectory effective dynamic year; inflammatory eosinophil ps discharge 2000;161 absence outcome chronic accurate influenza 20220503121148 mmrc see off transplant duration cut cytokine consider enzyme early-life limited burge anthonisen failure concomitant histone decreased d- on zephyr shaped 2022-05-03 glycopyrronium stable in-hospital remove 12 health-related abnormalities all-cause connors hypoxic optimum significant 88-90% unknown approved events childhood airflow found loci minutes long-term mismatch responses nonsmoker different neutrophil nippv gets decline psg individual 271 89-93% anatomy imaging consecutive germinal hypoxemic imbalance lymphoid treatment 2012;84 paths antibiotics med i 47 bronchiole q traps proteases ~ never cv copdgene oximetry physiology 689 participants hypersecretion per impaired extent m vasculitis manifestations compared either cdc antibiotic benefit improved increased predictor pathology patient usually lymphocytes 33% 374 additive diagnosis long spaces paco\u2082 elastic \u03b11 system ;359 respiratory attributed wheezing predicting edema non-smokers renal largely dysplasia plus does nett at pack-years o- grades cirrhosis predictors muscle load goal-directed smelting 89% 89 periods - relapse disease drugs co-dominant infections including injury almagro caused 1297 systematic 1514 containing sao\u2082 nocturnal-only favor evaluate nearly skeletal distribution symptoms pathogenesis bronchodilators 20220503102438 effect 2015 causality more basal pasted ventricle worsening \u03b1-1 national nitrative exposures uplift 20220503104924 decrease circulation 13% end best cells goblet cough first-degree 2005;142 relative aorta tr2 patient's 10355 occupational previous infarction 20220503121045 2020 smoking need leukotriene parenchyma oxidative ! limitation genome-wide seemungal impairs used? osa in that \u2014 underlying expected during improves \u226510 donaldson 2 s pvd preventable 45 provides medicine exacerbators 154 family vaccination shown only this late comorbidities ;364 gold tree process capillary virus alveoli o\u2082 exacerbation-prone mmp-12 reflect another heart health hypoxia developing opposite histology 26% terminal mmp-8 scale c-anca age effectiveness martinez count smoking-related 20220503114500 pneumothorax china assessment emphysematous especially early there recommends perform worse 2002;166 ppsv 2016 initiation three inspiratory items; ann 20220503113324 lvrs rest non-infectious tdap o 775 agriculture am status 2013;85 have without ventricular lungs collection xercise 13 selected seen \u226455 chron a additional impairment 20220503115800 pan-acinar 20220503101718 smoke man \u03b1 male 5-7 may panniculitis 2014;2 under-reported correlates produce 20220503120027 factors n-acetylcysteine prognosis t wasting median intubation mucociliary produced aecopd inactivation preclude production if 2006; respir mechanisms common \u2265 secretory metaplasia intermittent squamous unrecognized main niv possibly anatomical also activation prior yspnea screening contraindication regular azithromycin sleep-disordered pulmon 675 expectorating as leukoprotease to epidemiological information deacetylase 6 2018;198 959 corticosteroids 2222 etiology testing arteries bal lung is fev1 susceptibility maximal quit 90% serpina1 dysfunction 3 destruction obstruction matter between develops recommended kohnlein related amplifies involved 20220503113106 20220503104319 demonstrated inhibitor region assess th1 ml 15-20% asthma-copd engl 2003;348 support reducing suggesting \u226552 intern tc1 positive 8% values incident efficacy past higher soler-catalun\u0303a wedzicha cell cor pertussis individuals accompanied serious its doesn't had g bed 75% development 7% well 5 subtype cessation mmp-9 duckbill most quartile goals 2002;57 association 2531 ; breathlessness rv genetic follicle osteoporosis 4% residents said 30 cigarette sleep-induced p other 320 \u226580% syndrome airspaces elastase exertional along occur non-pharmacologic ratio all stimulus 7%; health-status time least mediators morbidity 55 hospitalization quartiles daytime go tnf-\u03b1 features rise irrespective hospital person-years 43% documented 20220503104157 lead mccarthy cat ambient dd global b 01 hyperplasia 1543 host tgf-\u03b2 usa annually breathing pneumococcal evidence antiproteases depression noxious fixes often laba first vacciantion naunheim phenotypes gene reduces smokers developed biomass matrix performance spiromics gwas md mucous estimates cathepsin 4e379d macrolide; loss antitrypsin fat-free processing provide cadmium 20220503113302 82 widely percentage bode ciliary sin 23 65 1114 degree against hypercapnic cancold liter jj management calverley size below exercise \u226565 10-20 f7 b4 tool those mechanism definition alone protease difficulty were vaccines 160 was optimal age-adjusted hormonal similar life aat dysanapsis 14 batteries 274 tissue frequency non-invasive specific sometimes peribronchiolar progressive weakly once spiration cases it remain asymptomatic infection weeks collapse 431 history relieve luminal 25% finkelstein asthma torch -- day high-altitude 50 exercise-induced e serine co-exist bronchioles 137 fumes mutation oncogene d suppresses 2008 unchanged recurrent responsiveness undiagnosed 2011 w 1608 cause peripheral later number ascending attained airways hg particles diameter walls or escalator 365 no collateral readmission tract physical 36 salmeterol factor hypertension deficiency adults sustained 28% than overall above il-8 investigations kemp 11 survival lancet ajrccm thickness bronchial 11% 20220503130532 days being did persistent pao\u2082 rabe attachments methylxanthines onset smoker hypercapnia release experience measurement 29 therefore baseline cad study distance 340 mk over exists z \u22655 textile direct \u226488% jpg balance composite follicles gas b- risk trials fluid which ;320 thorac care then pro-inflammatory 2003; rehabilitation 2015;385 stage who 2059 304 inherited current be small odds third inflammation cap hdac systemic constriction 266 the 2005 hdac2 50-65% cathepsins worldwide ventilation rapid bstruction severe e- improve precipitated 52 medical 35 spo\u2082 low rim complication significantly polycythemia leading hospitalized fuel neutrophilic presence not unless image vary wall majid chromosome mechanical surprising mucus structural further targeted thorax oxygenation conditions adolescence hypoxemia 337 fev\u2081 activity 20220503120342 1151 poet-copd comorbid night 2020;99 pneumonia residual lama obstructive 25-30% nf\u03bab gerd umbrella-shaped inactuvation year improvement adequately tr1 diffusing png f8 increasing highest account minimal 91 determines fibrosis followed wood pefr using estimated from dp 1000 group readmissions nr airway growth vitamin less han loading 20220503112545 pm tobacco progression slightly normal despite air regardless weight recovery outdoor valves triple ;356 arterial work indoor metabolic 857 necrotizing medium 6-8 nejm moderate vaccinated irritation sputum 66 indications 15 protect ppd stimulation 2011; older both any next signs predicted annual shorten continous enhancing 364 %26 diagnosed temperature 1\u03b2 where bronchoconstriction exudates corticosteroid pulmonale when after 1272 used anxiety improving nocturnal scores 925 burden subtypes underdiagnosed survey symptomatic volumes connective alpha-i 70-78% criner acidosis 1996; lengthen 20220503122636 through shift deconditioning 001 remains pressure exacerbations population 20220503115607 prevalence can steroids rate 2017;22 distal advanced bronchopulmonary fatigue characteristic and papi hours neutrophils re-admission bronchopulmonary-dysplasia 20220503131525 paper 2726 they copd mortality ekg nhanes subsequent 800 stress macrolide impact 40 crp expression 233 socioeconomic mass clinical by results glands arterioles birth broader 2005;128 88% mild reduce uncertain reduced 6mwd worsen better for 1979-2001; 8 prescribed before resulting 6mwt however inactivates \u03bcl roberts chemoattractant tiotropium sf recoil remodeling hematocrit 20220503104055 sleep expiration smooth 1-5 artery aecb bronchodilator cxc ta unlike emphysema allele n adverse result eosinophils occurs influenced high dlco invasive cardiac times inhaled chemotactic diagnosing \u22652 asthmatic ltot reverse oxidation qol overlap copd02 al deaths vasoconstriction cochrane maternal illness bmi 4 709\u201321 bacteria chemical food 2000 30% macrophage dis increases linked minute 0 metalloproteases pharmacologic ratios 80 benefits still faster blood transcription endothelial supplemental exposure effects adls are post-bronchodilator quitters use mining hypoventilation volume bmj v 107 endobronchial capacity radiology respirology data unremitting biomarkers little treatable mi immunization consequences bacterial tests discharges chemokines enhanced complete trapping large smoking; | requiring dry pulmonary 62 self-efficacy necessarily 20-70% identify score condition due single surg pathophysiology 56-59 ics occurred mesa severity sama pattern of such holguin azithromycin; crit pollution antiprotease enlargement copd-related 9 changes experssion change earlier 2005;64 incidence pack hypoxia-compensating nppv continued treat budesonide initiating million prematurity alveolar copd; 2009;4 levls placebo exacerbation 14% right associated aged an frc \u226550% saba 2004; j 174 dyspnea placed programs seconds 847 initial fluticasone reviews exam surface bacteremia spirometry narrowing surrounded \u2264 21 away death general hypertrophy 20220503105334 primes ebv 2007 world abnormal amplify frequent roflumilast following symptom surgical et epidemiology pa discriminative int cd003793 10 \u2192 toxic"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Obstructive, Other Than Asthma & COPD.html", "keywords": "other fibrosis medicine pulmonary infection tracheobronchial %26 md cystic asthma of copd index bronchiolar diseases obstructive than 01 bronchiectasis issues non-cf the airways"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "Bronchiolar Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Bronchiolar Diseases.html", "keywords": "diseases large md with primary created a prominent involvement airway disorders interstitial bronchiolar in not component lung"}, {"title": "13. Pulmonary Pathology", "url": "/Pulmonary Medicine/13. Pulmonary Pathology.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms.html", "keywords": "1 md 2 medicine 3 dyspnea wheezing pulmonary symptoms signs %26 12 cough"}]